Get started
Author

Philip S. Hobson

Observed names: Hobson, Philip, Hobson, Philip S., Hobson, Philip Stanley, P Hobson, P. Hobson, P. S. Hobson, Philip Hobson, Philip S Hobson, Philip S. Hobson, philip Hobson (10030928)
Observed institutions: Guy's Hospital, King's College London, The Francis Crick Institute, Asthma UK, King's College Hospital, Imperial College London, Medical Research Council
ORCID: 0000-0001-5117-2994
Observed ORCID: 0000-0001-5117-2994
OpenAlex ID: A5043626166
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans
2020 · Kevin W. Ng, Nikhil Faulkner, et al. · Science · 884
Lung adenocarcinoma promotion by air pollutants
2023 · William Hill, Emilia L. Lim, et al. · Nature · 803
Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination
2021 · Emma C Wall, Mary Wu, et al. · The Lancet · 491
PDF
Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA
2023 · Christopher Abbosh, Alexander M. Frankell, et al. · Nature · 381
The evolution of lung cancer and impact of subclonal selection in TRACERx
2023 · Alexander M. Frankell, Michelle Dietzen, et al. · Nature · 315
PDF
The evolution of non-small cell lung cancer metastases in TRACERx
2023 · Maise Al Bakir, Ariana Huebner, et al. · Nature · 251
PDF
RETRACTED ARTICLE: Antibodies against endogenous retroviruses promote lung cancer immunotherapy
2023 · Kevin W. Ng, Jesse Boumelha, et al. · Nature · 248
PDF
Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers
2020 · Catherine F Houlihan, Nina Vora, et al. · The Lancet · 219
PDF
Genomic–transcriptomic evolution in lung cancer and metastasis
2023 · Carlos Martínez-Ruiz, James R. M. Black, et al. · Nature · 202
PDF
Body composition and lung cancer-associated cachexia in TRACERx
2023 · Othman Al-Sawaf, Jakob Weiss, et al. · Nature Medicine · 147
PDF
Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer
2024 · Katey S.S. Enfield, Emma Colliver, et al. · Cancer Discovery · 133
PDF
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC
2021 · Emma C Wall, Mary Wu, et al. · The Lancet · 116
PDF
Evolutionary characterization of lung adenocarcinoma morphology in TRACERx
2023 · Takahiro Karasaki, David A. Moore, et al. · Nature Medicine · 115
PDF
Bacillus subtilis spores: A novel microparticle adjuvant which can instruct a balanced Th1 and Th2 immune response to specific antigen
2007 · Andrew G. C. Barnes, Vuk Cerovic, et al. · European Journal of Immunology · 108
PDF
Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma
2025 · James R. M. Black, Gabor Bartha, et al. · Nature Medicine · 107
PDF
Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells
2008 · Panagiotis Karagiannis, Josef Singer, et al. · Cancer Immunology Immunotherapy · 106
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study
2021 · Annika Fendler, Lewis Au, et al. · Nature Cancer · 90
PDF
Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients
2021 · Edward J Carr, Mary Wu, et al. · The Lancet · 86
PDF
Soluble CD23 Controls IgE Synthesis and Homeostasis in Human B Cells
2012 · Alison M Cooper, Philip S Hobson, et al. · The Journal of Immunology · 78
A constitutive interferon-high immunophenotype defines response to immunotherapy in colorectal cancer
2025 · Amelia Acha-Sagredo, Pietro Andrei, et al. · Cancer Cell · 69
Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometry
2021 · Febe van Maldegem, Karishma Valand, et al. · Nature Communications · 69
PDF
Mucosal immunization with DNA vaccines
2003 · P Hobson · Methods · 63
Ontogeny of human IgE-expressing B cells and plasma cells
2016 · F. Ramadani, H. Bowen, et al. · Allergy · 62
PDF
Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling
2024 · Sebastijan Hobor, Maise Al Bakir, et al. · Nature Communications · 52
PDF
The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinoma
2024 · Xiaoxi Pan, Khalid AbdulJabbar, et al. · Nature Cancer · 49
PDF
Works count: 87
Citation count: 5,544
H-index: 27
I10-index: 37
Year
Topic
Type